AzTrials
AzTrials

MenopauseNCT06480695

Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females

A study testing Nitrate-Rich Beetroot Juice, High Intensity Exercise and Moderate Intensity Exercise in people with Menopause, run by University of Virginia at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Read more about this study

Who is it for?
Ages 45 to 75 years, women onlyHealthy volunteers can take part
Conditions the study is for
Menopause
What is being tested?
Nitrate-Rich Beetroot Juice, High Intensity Exercise and Moderate Intensity Exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
1 Jul 2025to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 75 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Post-menopausal female (greater than age 45 but less than age 75)
  • Sedentary (does not exercise regularly or less than 2 bouts of exercise per week)
  • No major changes in medication in the last 3 months

Who cannot join

  • Smokers within last 5 years
  • Weight unstable (loss/gain of more than 3kg in the past 3 months)
  • Any medical condition that prevents the subject from exercising safely
  • Hormone replacement therapy (current or within last 3 months)
  • Diabetes
  • Currently or recently on vasoactive medications (i.e., calcium channel blockers, statins, ACE or renin inhibitors, ARBs, nitrates, alpha- or beta-blockers, diuretics, proton pump inhibitors, etc.)
Show all 9Show fewer
  • Oral antibiotic use within previous four weeks
  • Oral disease or poor oral health as determined by the Oral Health Questionnaire
  • Using an antibacterial mouthwash or a mouthwash containing chlorhexidine and unwilling to discontinue use

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Student Health and Wellness Building - Department of Kinesiology

    Charlottesville, Virginia, 22903

    Macy Stahl, 434-924-1655, mes4hm@uvahealth.org

    Recruiting

Other trials in United States

About this study

Official title: Effects of Exercise Training Intensity and Inorganic Nitrate Supplementation on Vascular Health and Fitness in Post-Menopausal Females

Menopause greatly increases cardiovascular disease risk (CVD). Current exercise guidelines are inadequate to ameliorate this risk and higher intensity exercise may be necessary for cardiovascular benefits in postmenopausal females. Oral nitrate supplementation enhances exercise performance and CVD risk profile in several clinical conditions. The investigators recently reported that 3-days of nitrate supplementation in postmenopausal females enhances acute post-exercise vascular function, in an intensity dependent manner. The effects of nitrate supplementation and exercise training over a longer training program remains unexplored. This investigation will examine the impact of exercise training intensity with and without inorganic nitrate supplementation, on CVD and fitness outcomes. Postmenopausal females will be tested for maximal oxygen uptake and lactate threshold before randomization to one of four groups: that inorganic nitrate-rich beetroot juice, or beetroot juice with nitrate extracted; and assigned to one-month of calorie matched high-intensity or moderate-intensity exercise training. Vascular function and fitness will be evaluated before and after training.

Conditions
Menopause
Being tested
Nitrate-Rich Beetroot Juice, High Intensity Exercise, Moderate Intensity Exercise, Nitrate-Depleted Placebo Beetroot Juice
Keywords
Inorganic Nitrate, Menopause, High Intensity Exercise, Vascular Health

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nitrate-Rich Beetroot JuiceDietary supplement

    Also called Inorganic Nitrate, James White Beet It

    subjects will consume 1 bottle of nitrate-rich beetroot juice (~400mg of nitrate each) 2x a day

  • High Intensity ExerciseBehavioural

    exercise at an intensity midway between the lactate threshold and VO2peak, from the screening test at an RPE of ~ 15-17

  • Moderate Intensity ExerciseBehavioural

    exercise at the RPE at LT associated an ~ RPE of 10-12

  • Nitrate-Depleted Placebo Beetroot JuiceDietary supplement

    Subjects will consume 1 bottle of nitrate-depleted beetroot juice 2x a day

Study groups in NCT06480695
Study groupRoleWhat they receive
Nitrate-Rich Beetroot Juice + High Intensity Exercise (HIE)ExperimentalParticipants assigned to this group will be instructed to consume 1 bottle of nitrate-rich beetroot juice (~400mg of nitrate each) 2x a day (morning a night) starting 2-hours before the first exercise session. Participants will complete a supervised bout of exercise on a treadmill 3x a week for 1-month. Participants will exercise at an RPE of 15-17 based on the participant's VO2peak test.
Receives: Dietary Supplement: Nitrate-Rich Beetroot Juice; Behavioral: High Intensity Exercise
Nitrate-Depleted Placebo Beetroot Juice + High Intensity Exercise (HIE)Placebo comparatorParticipants assigned to this group will be instructed to consume 1 bottle of nitrate-depleted beetroot juice 2x a day (morning a night) starting 2-hours before the first exercise session. Participants will complete a supervised bout of exercise on a treadmill 3x a week for 1-month. Participants will exercise at an RPE of 15-17 based on the participant's VO2peak test.
Receives: Behavioral: High Intensity Exercise; Dietary Supplement: Nitrate-Depleted Placebo Beetroot Juice
Nitrate-Rich Beetroot Juice + Moderate Intensity Exercise (MIE)Active comparatorParticipants assigned to this group will be instructed to consume 1 bottle of nitrate-rich beetroot juice (~400mg of nitrate each) 2x a day (morning a night) starting 2-hours before the first exercise session. Participants will complete a supervised bout of exercise on a treadmill 3x a week for 1-month. Participants will exercise at an RPE of 10-12 based on the participant's VO2peak test.
Receives: Dietary Supplement: Nitrate-Rich Beetroot Juice; Behavioral: Moderate Intensity Exercise
Nitrate-Depleted Placebo Beetroot Juice + Moderate Intensity Exercise (MIE)Placebo comparatorParticipants assigned to this group will be instructed to consume 1 bottle of nitrate-depleted beetroot juice 2x a day (morning a night) starting 2-hours before the first exercise session. Participants will complete a supervised bout of exercise on a treadmill 3x a week for 1-month. Participants will exercise at an RPE of 10-12 based on the participant's VO2peak test.
Receives: Behavioral: Moderate Intensity Exercise; Dietary Supplement: Nitrate-Depleted Placebo Beetroot Juice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vascular Endothelial Function (Flow-Mediated Dilation [FMD])

    Participants will be placed in a supine position with their left forearm slightly extended and supinated with legs straight. The arteries will be imaged using a high-resolution 7.5MHz linear array transducer at rest, during 5 minutes of forearm occlusion via cuff inflation, and continuously for 3 minutes post-occlusion; an EKG trigger will be used to capture images during end-diastole of the cardiac cycle.

    Measured: Baseline and after 1-month of exercise training

  2. Cardiorespiratory Fitness

    Peak aerobic capacity (VO2peak) will be assessed using a symptom-limited graded exercise test on a treadmill. An IV will be placed and lactate measured during rest and after the completion of every 3-minute stage to determine lactate threshold at VO2peak.

    Measured: Baseline and after 1-month of exercise training

Secondary outcomes (9)
  1. Oral Nitrate Reducing Capacity

    Assessment of the oral microbiome's ability to reduce nitrate to nitrite. This will be measured through an unstimulated saliva sample and a rinse of a standard nitrate solution.

    Measured: Baseline and after 1-month of exercise training

  2. Skeletal muscle perfusion

    Skeletal Muscle Blood Flow (straight gauge plethysmography) will be measured non-invasively using venous occlusion/strain-gauge plethysmography both at rest and during reactive hyperemia following 5-minutes of occlusion via the Hokanson A16. A strain gauge device will be place around the widest part of the participant's right calf. A blood pressure place around participant's ankle will be inflated for 60 seconds to eliminate foot circulation from the measurement. At the same time, a cuff placed on the thigh will be inflated to block venous blood flow. The cuff occlusion will be held for ~60 seconds ((several cardiac cycles (4-6 cycles)) to obtain resting blood flow measurements.

    Measured: Baseline and after 1-month of exercise training

  3. Peripheral and Central Blood Pressures

    Brachial artery blood pressures will be obtained using a standard sphygmomanometer. Aortic blood pressures will be obtained using applanation tonometry (SphygmoCor version 8.0, AtCor Medical).

    Measured: Baseline and after 1-month of exercise training

  4. 24-hour ambulatory blood pressure

    Blood pressure will be monitored using a standard ambulatory brachial artery blood pressure cuff (SunTech Oscar 2, SunTech Medical). Blood pressure measurements are programmed to be taken every 30-minutes during the day and every hour at night. This allows for monitoring of nighttime blood pressure changes and variations throughout the day.

    Measured: Baseline and after 1-month of exercise training

  5. Skeletal muscle microvascular perfusion (near-infra-red- spectroscopy)

    Tissue oxygenation will be captured noninvasively using non-invasive, near-infrared spectrometry (NIRS, PortaMon, Artinis Medical Systems B.V., The Netherlands) positioned on the gastrocnemius or vastus lateralis muscle.

    Measured: Baseline and after 1-month of exercise training

  6. Lipids

    A blood sample will be obtained to measure lipids.

    Measured: Baseline

  7. Hemoglobin

    A blood sample will be obtained to measure hemoglobin.

    Measured: Baseline and after 1-month of exercise training

  8. Plasma Nitrate

    A fasting blood draw will be taken. Following the blood draw, the participant will take one dose of Beetroot juice. The participant will then return to the lab three hours later for a second blood draw to assess level of nitrate in the plasma.

    Measured: Baseline and after 1-month of exercise training

  9. Plasma Nitrite

    A fasting blood draw will be taken. Following the blood draw, the participant will take one dose of Beetroot juice. The participant will then return to the lab three hours later for a second blood draw to assess level of nitrite in the plasma.

    Measured: Baseline and after 1-month of exercise training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2024
  2. Study start1 Jul 2025
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Subjects will be randomized to one-month of either high or moderate aerobic exercise training and then further randomized to nitrate or placebo.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06480695
Sponsor's protocol ID
HSR231665
Status last verified
Jul 2026
First submitted
17 Jun 2024
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Nitrate-Rich Beetroot Juice, High Intensity Exercise and Moderate Intensity Exercise in people with Menopause, run by University of Virginia at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Macy Stahl (434-924-1655, mes4hm@uvahealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vascular Endothelial Function (Flow-Mediated Dilation [FMD]) (time frame: Baseline and after 1-month of exercise training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in